Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Point prevalence and cumulative incidence of calcium pyrophosphate crystal arthropathy (CPPD) in Skåne, in 2014, age and sex stratified

From: Prevalence and incidence of non-gout crystal arthropathy in southern Sweden

 PrevalenceCumulative incidence
SexAge groupNumber of persons with diagnosisPopulation (n)Prevalence/100,000 persons95% CINumber of persons with diagnosisPopulation (n)Cumulative incidence/100,000 persons95% CI
All≥ 188691,022,5458580–91811,012,21886–10
WomenAll ≥ 18383519,3027467–8231514,76664–8
Women18–343143,72520940–6450143,16000–3
Women35–44883,016964451–1939082,34200–6
Women45–542083,24024031531–3736182,31520–8
Women55–644673,59662504668–8354473,84552–14
Women65–747370,99510,2828164–12,941769,138104–21
Women75–8410841,95625,74121,306–31,0881241,2582916–51
Women85+12522,77454,88746,054–65,388722,7083114–65
Men≥18486503,2439788–10650497,452108–13
Men18–343145,89320639–6350145,10200–3
Men35–441186,0061279683–2321285,00120–9
Men45–543384,97138842747–5472183,82410–7
Men55–648972,78112,2299926–15,058973,083126–24
Men65–7415468,25422,56319,262–26,4241866,3772717–43
Men75–8412133,70935,89630,027–42,895832,6412511–49
Men85+7511,62964,49451,396–80,8521211,42410558–186